Opdivo Qvantig is approved for solid tumors, including melanoma, renal cell carcinoma, and non-small cell lung cancer. The ...

Cambridge: AstraZeneca's Tagrisso (osimertinib) has been approved in the European Union (EU) for the treatment of adult ...

Artificial intelligence (AI)-aided analysis of pathology slides showed potential as a predictive biomarker for non-small cell ...

AstraZeneca, Daiichi Sankyo voluntarily withdrawn the MAA in the EU for datopotamab deruxtecan for patients with locally advanced or metastatic NSCLC: Cambridge, UK Friday, Decemb ...

The Food and Drug Administration announced it has approved nivolumab and hyaluronidase-nvhy, Opdivo Qvantig, from Bristol Myers (BMY) Squibb, ...

Life science investor Syncona said its investment Achilles Therapeutics has sold cancer study assets to AstraZeneca for $12m (£9.58m).

Immunotherapy has transformed cancer treatment, offering new avenues of hope for patients with advanced disease or limited ...

London stocks were set to nudge up at the open on Friday in very quiet trade, with most traders still away from their desks ...

New Delhi: Pharmaceutical major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the ...

(Alliance News) - Syncona Ltd on Friday said one of its investments Achilles Therapeutics PLC has sold its technology assets to AstraZeneca PLC for USD12 million. Syncona is a London-based investor in ...

Shares of ValiRx plc (LON:VAL – Get Free Report) were down 9% on Friday . The stock traded as low as GBX 0.66 ($0.01) and last traded at GBX 0.66 ($0.01). Approximately 4,225,518 shares traded hands ...

Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with ...